tradingkey.logo
tradingkey.logo
Search

Beta Bionics Inc

BBNX
Add to Watchlist
9.460USD
+0.260+2.83%
Close 05/15, 16:00ETQuotes delayed by 15 min
421.55MMarket Cap
LossP/E TTM
You can access the annual and quarterly cash flow statements of Beta Bionics Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2023Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-19.31%-23.83M
39.58%-8.63M
---8.73M
---13.59M
---19.98M
-124.97%-14.28M
---6.35M
Net income from continuing operations
23.59%-21.89M
25.64%-13.47M
---14.21M
---16.87M
---28.66M
3.93%-18.11M
---18.85M
Operating gains losses
-3.15%585.00K
1.70%538.00K
--385.00K
--347.00K
--604.00K
-2.76%529.00K
--544.00K
Other non-cash items
140.57%286.00K
224.88%1.30M
--300.00K
---372.00K
---705.00K
-41.98%-1.04M
---736.00K
Change in working capital
-26.92%-8.21M
58.74%-1.34M
--317.00K
---1.50M
---6.47M
-472.97%-3.24M
---566.00K
-Change in receivables
-53.41%1.37M
-22.75%-5.59M
---168.00K
---2.33M
--2.94M
-84.01%-4.56M
---2.48M
-Change in inventory
31.21%-1.80M
-39.70%-2.20M
---3.33M
---1.73M
---2.62M
-72.16%-1.58M
---916.00K
-Change in prepaid expenses
158.70%951.00K
63.39%-413.00K
---1.79M
---1.99M
---1.62M
-308.70%-1.13M
---276.00K
-Change in other current assets
-125.00%-1.00K
200.00%3.00K
---39.00K
--2.00K
--4.00K
103.45%1.00K
---29.00K
-Change in other current liabilities
-55.83%212.00K
10.86%868.00K
--711.00K
--1.54M
--480.00K
228.99%783.00K
--238.00K
Cash from non-recurring investing activities
Cash from operating activities
-19.31%-23.83M
39.58%-8.63M
---8.73M
---13.59M
---19.98M
-124.97%-14.28M
---6.35M
Investing cash flow
Net cash from continuing investing activities
313.51%1.38M
239.22%1.90M
--1.28M
--1.78M
--333.00K
79.23%561.00K
--313.00K
Capital expenditures
313.51%1.38M
239.22%1.90M
--1.28M
--1.78M
--333.00K
79.23%561.00K
--313.00K
Net cash flow from disposal of fixed assets
313.51%1.38M
239.22%1.90M
--1.28M
--1.78M
--333.00K
79.23%561.00K
--313.00K
Net cash flow from investment products
112.99%23.22M
108.80%2.56M
--10.77M
--7.95M
---178.79M
58.00%-29.10M
---69.30M
Net cash flow from other investing activities
--0.00
--45.30M
----
----
----
--0.00
----
Cash from non-current investing activities
Net cash flow from investing activities
112.19%21.84M
102.22%658.00K
--9.49M
--6.17M
---179.12M
57.39%-29.66M
---69.61M
Financing cash flow
Cash flow from continuous financing activities
-99.70%623.00K
-98.14%1.06M
--2.65M
--42.00K
--211.12M
632033.33%56.89M
--9.00K
Net cash flow from common stock issuance/repurchase
----
---904.00K
--0.00
--0.00
--211.02M
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
--59.66M
--0.00
Proceeds from stock option exercised by employees
535.71%623.00K
5208.11%1.96M
--2.65M
--42.00K
--98.00K
311.11%37.00K
--9.00K
Proceeds from issuance of warrants
----
----
----
----
----
--1.00K
--0.00
Net cash flow from other financing activities
--0.00
67.78%-904.00K
----
----
----
---2.81M
----
Net cash from non-recurrent financing activities
Net cash from financing activities
-99.70%623.00K
-98.14%1.06M
--2.65M
--42.00K
--211.12M
632033.33%56.89M
--9.00K
Net cash flow
Beginning cash balance
3.75%31.68M
119.47%38.59M
--35.17M
--42.55M
--30.53M
-82.87%17.58M
--102.61M
Current period cash flow changes
-111.40%-1.37M
-153.35%-6.91M
--3.41M
---7.38M
--12.02M
117.05%12.95M
---75.95M
Ending cash balance
-28.78%30.31M
3.75%31.68M
--38.59M
--35.17M
--42.55M
14.50%30.53M
--26.67M
Free cash flow
-24.13%-25.21M
29.04%-10.53M
---10.01M
---15.37M
---20.31M
-122.82%-14.84M
---6.66M
Currency unit
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI